Rock Springs Capital Management LP
104 holdingsFiling period: 2026-06-30Current AUM: $1.91Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 1.11M | $207.0M | $211.4M | 11.05% | -104,255 | 2026-06-30 |
| 2 | TVTX | Travere Therapeutics Inc | 2.18M | $123.8M | $109.8M | 5.74% | +701.1K | 2026-06-30 |
| 3 | LLY | Eli Lilly & Co | 98.7K | $118.4M | $139.9M | 7.31% | -- | 2026-06-30 |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | 175.0K | $94.0M | $75.3M | 3.93% | +4.0K | 2026-06-30 |
| 5 | MIRM | Mirum Pharmaceuticals Inc | 798.1K | $93.4M | $67.8M | 3.54% | -13,149 | 2026-06-30 |
| 6 | RYTM | Rhythm Pharmaceuticals Inc | 692.6K | $76.9M | $64.1M | 3.35% | +2.9K | 2026-06-30 |
| 7 | KYMR | Kymera Therapeutics Inc | 453.2K | $52.0M | $57.4M | 3.00% | -43,715 | 2026-06-30 |
| 8 | ARGX | Argenx SE | 52.8K | $48.9M | $47.1M | 2.46% | -45,750 | 2026-06-30 |
| 9 | — | Ascendis Pharma A/S | 168.8K | $45.0M | $45.0M | 2.35% | -- | 2026-06-30 |
| 10 | XENE | Xenon Pharmaceuticals Inc | 683.9K | $41.3M | $25.6M | 1.34% | -79,113 | 2026-06-30 |
| 11 | SRRK | Scholar Rock Hldg Corp | 715.5K | $39.3M | $31.4M | 1.64% | -24,364 | 2026-06-30 |
| 12 | INSM | Insmed Inc | 362.1K | $38.6M | $40.8M | 2.13% | +47.9K | 2026-06-30 |
| 13 | PEN | Penumbra Inc | 115.8K | $36.5M | $36.9M | 1.93% | -4,750 | 2026-06-30 |
| 14 | GPCR | Structure Therapeutics Inc | 640.3K | $34.4M | $14.0M | 0.73% | +100 | 2026-06-30 |
| 15 | RARE | Ultragenyx Pharmaceutical in | 967.9K | $32.3M | $15.6M | 0.81% | -250,918 | 2026-06-30 |
| 16 | IRTC | Irhythm Holdings Inc | 269.6K | $32.1M | $33.3M | 1.74% | +7.9K | 2026-06-30 |
| 17 | ISRG | Intuitive Surgical Inc | 76.5K | $30.4M | $33.0M | 1.73% | -5,540 | 2026-06-30 |
| 18 | AGL | Agilon Health Inc | 262.6K | $28.1M | $22.3M | 1.16% | +2.6K | 2026-06-30 |
| 19 | UNH | Unitedhealth Group Inc | 63.8K | $26.5M | $25.9M | 1.36% | +10.8K | 2026-06-30 |
| 20 | CLDX | Celldex Therapeutics Inc New | 699.1K | $26.0M | $21.0M | 1.10% | +48.9K | 2026-06-30 |
| 21 | ERAS | Erasca Inc | 1.40M | $25.7M | $20.1M | 1.05% | +298.7K | 2026-06-30 |
| 22 | NBIX | Neurocrine Biosciences Inc | 144.8K | $24.4M | $21.1M | 1.10% | -5,700 | 2026-06-30 |
| 23 | ELVN | Enliven Therapeutics Inc | 464.6K | $23.6M | $20.6M | 1.07% | -361,875 | 2026-06-30 |
| 24 | THC | Tenet Healthcare Corp | 125.0K | $23.4M | $34.2M | 1.78% | -- | 2026-06-30 |
| 25 | DXCM | Dexcom Inc | 343.0K | $23.1M | $28.2M | 1.47% | -12,600 | 2026-06-30 |
← Scroll →
Page 1 of 5